PRNewsWire
02 Aug 2026, 12:43 UTC · 1h ago
GRAL Deadline: GRAL Investors Have Opportunity to Lead GRAIL, Inc. Securities Fraud Lawsuit
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.

PRNewsWire
02 Aug 2026, 12:43 UTC · 1h ago
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.

What the story claims
3 claims · each scored for market impact
GRAIL, Inc. is facing a securities fraud class action lawsuit alleging the company misled investors regarding the NHS-Galleri trial results. — Securities fraud allegations and legal challenges typically create downward pressure on stock prices due to potential liabilities and damaged investor trust.
-0.60The lawsuit claims the NHS-Galleri trial period was insufficient to demonstrate the achievability of a reduction in Stage III-IV cancers. — Failure to meet primary endpoints in a core clinical trial directly undermines the company's value proposition and product efficacy claims.
-0.50Plaintiffs allege that GRAIL concealed material adverse facts and refused to provide detailed top-line results from the NHS-Galleri study. — Allegations of lack of transparency and data concealment increase the risk profile of the company's management and regulatory standing.
-0.30Which stocks this story touches
Continue reading
6 related stories
Search tags
The company is mentioned as being subject to a securities fraud lawsuit.
The company is facing a securities fraud class action lawsuit alleging it made false and misleading statements about clinical trial results.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
How the impact breaks down
Where the story's weight lands
Stocks most exposed
Modeled from each name's sensitivity to this story
No stock impact ranking available yet.

Newsfile Corp
12h ago